US Stocks
/
NovoCure Limited Share Price

NovoCure Limited Share Price

NASDAQ: NVCR | Small Cap
$14.57
+$0.35 (2.50%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

NovoCure Limited Stock Performance

Open
$14.17
Prev. Close
$14.22
Circuit Range
N/A
Day Range
$14.17 - $14.74
Year Range
$9.83 - $21.31
Volume
74,897
Average Traded
$14.59

NovoCure Limited Share Price Today

As of 10 October 2026, NovoCure Limited's share price is $14.57. The stock opened at $14.17, compared to its previous close of $14.22. During today's trading session, NovoCure Limited's share price traded between $14.17 and $14.74, with an average price of $14.46. Over the past 52 weeks, the stock has recorded a high of $21.31 and a low of $9.83. In terms of performance, NovoCure Limited's share price has declined by 4.08% over the last six months and is up 13.96% on a year-on-year basis.

NovoCure Limited Share Price Chart

$14.17$14.74
L
Show Current Price
H

NovoCure Limited Stock Fundamentals & Key Indicators

Market Cap
$1.62B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.28
Revenue (TTM)
$655.35B
Return On Equity (TTM)
-43.94%
Profit Margin
-20.79%
Debt to Equity
0.58
Quarterly Earnings Growth YoY
57.98%

NovoCure Limited Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$167.20$174.35$174.06$183.58
Net Profit-$37.27-$24.50-$71.14-$15.66
Net Profit Margin-22.29%-14.05%-40.87%-8.53%
Income ChangeN/A34.26%-190.37%77.99%

NovoCure Limited Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$537.84$509.34$605.22$655.35
Net Profit-$92.53-$207.04-$168.63-$136.23
Net Profit Margin-17.20%-40.65%-27.86%-20.79%
Income ChangeN/A-123.75%18.55%19.21%

About NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

NovoCure Limited Historical Returns

MonthOpenCloseChange %
Oct 2026
$15.88
$14.60
-8.67%
Sep 2026
$17.51
$15.98
-11.17%
Aug 2026
$15.05
$17.99
+21.14%
Jul 2026
$15.38
$14.85
-1.75%
Jun 2026
$17.18
$15.12
-11.30%
May 2026
$15.40
$17.04
+12.14%
Apr 2026
$11.08
$15.20
+39.28%
Mar 2026
$13.63
$10.91
-20.10%
Feb 2026
$12.25
$13.65
+9.94%
Jan 2026
$12.97
$12.42
-3.80%
Dec 2025
$12.12
$12.91
+0.86%
Nov 2025
$12.77
$12.80
+0.08%

NVCR Share Price FAQs

What is NovoCure Limited share price today?

chevron-up
NovoCure Limited share price today is $14.57 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of NovoCure Limited stock?

chevron-up
The 52 week high of NovoCure Limited stock is $21.31, while the 52 week low is $9.83 as of 10 Oct '26.

What is NVCR's market capitalisation today?

chevron-up
NVCR market capitalisation is $1.62B as of October 10, 2026, at 3:01 am IST.

What is NVCR's net income for the last quarter?

chevron-up
NVCR's net income for the last quarter is -15.66B USD.

What is the 5 year returns of NVCR?

chevron-up
The 5 year returns of NVCR is -85.79% as on 10 Oct '26.

What is the high & low stock price of NVCR today?

chevron-up
NVCR stock price hit a high of $14.74 and low of $14.17 as of 10 Oct '26.

Can I buy NVCR shares in India?

chevron-up
Yes. You can buy NVCR in India by opening an international trading account.